Wolverine Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-300
Closed -$6.88K 1699
2024
Q3
$6.88K Hold
300
﹤0.01% 1364
2024
Q2
$8.66K Hold
300
﹤0.01% 1348
2024
Q1
$6.19K Hold
300
﹤0.01% 1365
2023
Q4
$8.12K Buy
+300
New +$7.87K ﹤0.01% 1412
2022
Q1
Sell
-1,000
Closed -$100K 2232
2021
Q4
$100K Buy
+1,000
New +$103K ﹤0.01% 1356

Other funds holding GH

Wolverine Asset Management's GH Position: Q2 2025 in Review

Wolverine Asset Management sold out of Guardant Health (GH) in Q2 2025, closing a stake of 5,985 shares — an estimated $267K sold.

Wolverine Asset Management first reported a position in GH in Q2 2020 and held it in 8 quarters. The position peaked at $710K in Q3 2024. 364 funds tracked by Wall St. Rank hold GH as of Q2 2025.

  • Wolverine Asset Management reported no remaining Guardant Health position as of Q2 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 5,985 Guardant Health shares in Q2 2025, an estimated $267K.
  • Wolverine Asset Management first reported a position in Guardant Health in Q2 2020 and held it in 8 quarters.
  • Wolverine Asset Management's Guardant Health position peaked at $710K in Q3 2024.
  • 364 funds tracked by Wall St. Rank held Guardant Health as of Q2 2025.

Based on Wolverine Asset Management's 13F filing for Q2 2025, filed 4 Aug 2025.